April 23rd 2025
The investment will be done over five years and will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple US states.
NGS abbreviates drug discovery timelines.
Addressing the Analytical Challenge of Meeting Quick Turnaround Times (AAPS PharmSci 360)
November 2nd 2023Hollie Barton, senior director, Chromatographic Services, for the PPD clinical research business of Thermo Fisher Scientific, discusses ways that labs are addressing the pressure of rapid analytical turnaround times.